4.89
price up icon4.49%   0.21
pre-market  시장 영업 전:  4.98   0.09   +1.84%
loading

Vanda Pharmaceuticals Inc 주식(VNDA)의 최신 뉴스

pulisher
Jun 17, 2025

Insider Sell: Stephen Mitchell Sells 7,000 Shares of Vanda Pharm - GuruFocus

Jun 17, 2025
pulisher
Jun 13, 2025

DC Circ. Urged To Reject Approval For Braille-Free Drug Label - Law360

Jun 13, 2025
pulisher
Jun 10, 2025

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial Evaluating VCA-894A in Charcot-Marie-Tooth disease Type 2S - StreetInsider

Jun 10, 2025
pulisher
Jun 10, 2025

Vanda Pharmaceuticals Inc. Announces First Patient Dosed in A Trial Evaluating VCA-894A in Charcot-Marie-Tooth Disease Type 2S - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Vanda Pharmaceuticals Announces First Patient Dosed In A Trial Evaluating VCA-894A In Charcot-Marie-Tooth Disease Type 2S - MarketScreener

Jun 10, 2025
pulisher
Jun 10, 2025

Vanda Pharmaceuticals Announces First Patient Dosed in a Trial E - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Vanda Pharmaceuticals (VNDA) Initiates First Human Trial for Ant - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Vanda's Breakthrough: First-Ever Personalized Treatment Trial Launches for Ultra-Rare CMT2S Disease - Stock Titan

Jun 10, 2025
pulisher
Jun 09, 2025

Director Honore Tage was granted 59,225 shares, increasing direct ownership by 92% to 123,469 units (SEC Form 4) - Quantisnow

Jun 09, 2025
pulisher
Jun 05, 2025

Vanda Approves Key Proposals at Annual Meeting - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

SEC Form S-8 filed by Vanda Pharmaceuticals Inc. - Quantisnow

Jun 05, 2025
pulisher
Jun 05, 2025

CLASS ACTION UPDATE for SPB, VNDA and ARA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 03, 2025

Class Action Reminder Vanda Pharmaceuticals Inc. (VNDA), Stamps.com Inc. (STMP) & Syneos Health, Inc. (SYNH)Bronstein, Gewirtz & Grossman, LLC - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 03, 2025

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In Vanda Pharmaceuticals, Inc. To Contact The Firm - ACCESS Newswire

Jun 03, 2025
pulisher
May 29, 2025

Judge Favors Vanda But Seeks Deal Over Drug Approval - Law360

May 29, 2025
pulisher
May 27, 2025

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting | VNDA Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

Vanda Pharmaceuticals Announces Presentation at 2025 ASCP Annual Meeting - PR Newswire

May 27, 2025
pulisher
May 27, 2025

SEC Form DEFA14A filed by Vanda Pharmaceuticals Inc. - Quantisnow

May 27, 2025
pulisher
May 27, 2025

Clinical Data: Vanda Unveils Key Bioequivalence Study Results for Next-Gen Psychiatric Drug at Major Conference - Stock Titan

May 27, 2025
pulisher
May 22, 2025

Justices Urged To Undo Denial Of Fast Track For Gastro Drug - Law360

May 22, 2025
pulisher
May 22, 2025

Insider Buying: Mihael Polymeropoulos Acquires Additional Shares of Vanda Pharmaceuticals Inc (VNDA) - GuruFocus

May 22, 2025
pulisher
May 21, 2025

President and CEO Polymeropoulos Mihael Hristos bought $43,995 worth of shares (10,000 units at $4.40), increasing direct ownership by 0.43% to 2,325,731 units (SEC Form 4) - Quantisnow

May 21, 2025
pulisher
May 20, 2025

Insider Buying: Mihael Polymeropoulos Acquires 20,000 Shares of Vanda Pharmaceuticals Inc (VNDA) - GuruFocus

May 20, 2025
pulisher
May 19, 2025

President and CEO Polymeropoulos Mihael Hristos bought $84,472 worth of shares (20,000 units at $4.22), increasing direct ownership by 0.87% to 2,315,731 units (SEC Form 4) - Quantisnow

May 19, 2025
pulisher
May 18, 2025

Mystics enter new partnership with Vanda Pharmaceuticals - Monumental Sports Network

May 18, 2025
pulisher
May 17, 2025

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025 - The Malaysian Reserve

May 17, 2025
pulisher
May 16, 2025

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025 | VNDA Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

Mystics tap D.C.'s Vanda Pharmaceuticals as new jersey sponsor - The Business Journals

May 16, 2025
pulisher
May 16, 2025

Monumental Sports & Entertainment Announces Vanda Pharmaceuticals Inc. as Official Partner and Jersey Patch Partner for the Washington Mystics - Monumental Sports

May 16, 2025
pulisher
May 14, 2025

Vanda Pharmaceuticals (VNDA) Receives Overweight Rating from Can - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Vanda Pharmaceuticals (VNDA) Projected to Transform with Overwei - GuruFocus

May 14, 2025
pulisher
May 14, 2025

Vanda Pharmaceuticals assumed with an Overweight at Cantor Fitzgerald - TipRanks

May 14, 2025
pulisher
May 13, 2025

Vanda Receives Positive CHMP Opinion for HETLIOZ® (tasimelteon) for the Treatment of Non-24-Hour Sleep-Wake Disorder in the European Union | Libero Quotidiano.it - Libero Quotidiano

May 13, 2025
pulisher
May 10, 2025

Vanda Pharmaceuticals’ (VNDA) “Buy” Rating Reiterated at HC Wainwright - Defense World

May 10, 2025
pulisher
May 09, 2025

Vanda pharmaceuticals outlines $210M-$250M revenue target for 2025 amid product launches - MSN

May 09, 2025
pulisher
May 09, 2025

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025
pulisher
May 09, 2025

Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Vanda Pharmaceuticals’ Earnings Call: Growth Amid Challenges - TipRanks

May 08, 2025
pulisher
May 08, 2025

Vanda Pharmaceuticals Inc (VNDA) Q1 2025 Earnings Call Highlights: Revenue Growth Amid Rising ... - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Vanda: Q1 Earnings Snapshot - MySA

May 08, 2025
pulisher
May 08, 2025

Vanda Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks

May 08, 2025
pulisher
May 07, 2025

Vanda Pharmaceuticals Q1 2025 Earnings: EPS Loss of $0.50 Beats - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Earnings call transcript: Vanda Pharmaceuticals misses Q1 2025 forecasts - Investing.com

May 07, 2025
pulisher
May 07, 2025

Capitals Announce Game 3 Watch Party at The Wharf as Part of Additional Playoffs Initiatives Presented by Vanda Pharmaceuticals Inc. - NHL.com

May 07, 2025
pulisher
May 07, 2025

Vanda Pharmaceuticals Q1 2025 Earnings: EPS Loss of $0.50 Beats Estimate, Revenue Surpasses Forecast at $50 Million - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Vanda Pharmaceuticals (VNDA) Reports Strong Q1 Revenue and Expands Product Pipeline | VNDA Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

Vanda Pharmaceuticals Reports First Quarter 2025 Financial Results - StreetInsider

May 07, 2025
pulisher
May 07, 2025

HC Wainwright & Co. Reiterates Buy Rating on Vanda Pharmaceutica - GuruFocus

May 07, 2025
$20.44
price down icon 1.45%
$36.19
price up icon 0.86%
$22.62
price up icon 6.70%
$98.24
price up icon 0.64%
$108.26
price up icon 0.70%
biotechnology ONC
$244.32
price down icon 0.34%
자본화:     |  볼륨(24시간):